Patrick Aldrin-Kirk

Company: rAAVen Therapeutics
Job title: Chief Scientific Officer
Seminars:
Development of Capsid Engineering 9:00 am
Advancing capsid engineering to reduce immunogenicity Maximisation of stability via engineering Discussing the specifics of enhancing capsid design for AAV vectorsRead more
day: Conference Day One
Chair’s Opening Remarks 9:20 am
day: Conference Day Two
Chair’s Opening Remarks 8:45 am
day: Conference Day One